ELVN-002 is a small molecule commercialized by Enliven Therapeutics, with a lead...
NN-9931 is a recombinant peptide commercialized by Novo Nordisk, with a leading ...
Moderna has announced the halt of its project to build a messenger ribonucleic a...
The site expansion is set to add 680 jobs to the site and expand Fujifilm’s cont...
Eliem Therapeutics has announced an agreement for the acquisition of development...
Novartis has signed an exclusive strategic licence agreement for Arvinas’ ARV-76...
The US FDA has granted approval for AstraZeneca's FASENRA in children aged six t...
The collaboration pact will see Rallybio gaining a $6.6m equity investment from ...
As the UK tackles several drug shortages, UK charities and pharmacists called fo...
SK Life Sciences Xcopri (cenobamate) is approved as an oral suspension mixed wit...
The FDA designation follows positive Phase II data announced recently.
Century Therapeutics will pay $35m upfront and an additional $10m milestone paym...
Discover the groundbreaking patent by Kyowa Kirin Co Ltd for a monoclonal antibo...
Discover a groundbreaking patent by MorphoSys AG for novel compounds targeting m...
ADMA Biologics Inc's innovative method for treating upper respiratory infections...
Innate Pharma plans to advance IPH45 towards clinical trials, with an investigat...
